Sensenig Bethany

Track

Insider profile

Performance

Overall performance
3.4
Performance over holding periods
3.4
30 days 90 days 120 days
Average return 35% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Sensenig Bethany's trades of Supernus Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
36.33
Quantity 98,649
Value US$2,385,938
Transaction date
Proposed sale
Price
0.14
Quantity 15,989
Value US$2,274
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-23 2026-02-19
PlS Planned sale
51,595 +30.0%
217.59
US$2,090,970 		51,595 +30.0% 217.59 US$2,090,970
2026-02-23 2026-02-19
PlS Planned sale
72,684 -44.1%
91.90
US$1,899,897 		72,684 -44.1% 91.90 US$1,899,897
2026-02-19 2026-02-19
PrS Proposed sale
98,649
36.33
US$2,385,938 		98,649 36.33 US$2,385,938
2025-08-18 2025-08-14
PlS Planned sale
5,369 -100.0%
42.25
US$226,840 		5,369 -100.0% 42.25 US$226,840
2025-08-14 2025-08-14
PrS Proposed sale
5,369
42.64
US$228,934 		5,369 42.64 US$228,934
2023-07-21 2023-07-21
PrS Proposed sale
15,989
0.14
US$2,274 		15,989 0.14 US$2,274
2023-04-21 2023-04-21
PrS Proposed sale
9,500
1.26
US$12,000 		9,500 1.26 US$12,000
2023-04-21 2023-04-21
S Sale
9,100 -18.1%
1.21
US$11,011 		9,100 -18.1% 1.21 US$11,011